PedAM
Pediatric Disease Annotations & Medicines
| Disease | arteriosclerosis |
| Phenotype | C0035435|rheumatic diseases |
| Sentences | 10 |
| PubMedID- 21912432 | Furthermore, it seems that systemic inflammation and mechanisms that do not involve conventional cvd risk factors and mets have an important role in the development of atherosclerosis in patients with rheumatic diseases. |
| PubMedID- 24412013 | Numerous autoimmune-inflammatory rheumatic diseases have been associated with accelerated atherosclerosis or other types of vasculopathy leading to an increase in cardiovascular disease incidence. |
| PubMedID- 22529523 | In particular, a lack of information exists on the relationship between antioxidants and accelerated atherosclerosis in patients with autoimmune rheumatic diseases. |
| PubMedID- 24615538 | Several autoimmune rheumatic diseases have been associated with accelerated atherosclerosis or other different types of vasculopathy depending on the underlying disease, leading to increased cardio- and cerebrovascular disease risk. |
| PubMedID- 23731870 | Few studies have explored the prevalence of cardiovascular risk factors and even fewer have used the surrogate vascular measures to document signs of early atherosclerosis in children with pediatric-onset rheumatic diseases. |
| PubMedID- 22899879 | Different validated techniques are currently available to determine subclinical atherosclerosis in patients with rheumatic diseases. |
| PubMedID- 21281743 | Numerous autoimmune-inflammatory rheumatic diseases have been associated with accelerated atherosclerosis or other types of vasculopathy leading to increased cardio- and cerebrovascular disease risk. |
| PubMedID- 26428207 | Objective: chronic inflammatory rheumatic diseases are associated with accelerated atherosclerosis, but data in ankylosing spondylitis (as) are limited and the relative contribution of inflammation versus classical cardiovascular (cv) risk factors remains a matter of controversy. |
| PubMedID- 23202900 | Defective vascular repair has been proposed as a process for premature atherosclerosis in rheumatic diseases and decreased numbers of circulating endothelial-progenitor cells have been described in ra [100] and systemic lupus erythematosus [101]. |
| PubMedID- 19758114 | The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. |
Page: 1